- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Expanding PrEP Access
Carl Schmid concludes with his thoughts on the future of PrEP therapy.
EP: 1.Creating a Successful HIV PrEP Program
EP: 2.Increasing the Uptake of HIV PrEP in the Community
EP: 3.Economic Impact of HIV
EP: 4.Population Health and HIV PrEP
EP: 5.Educating Patients About HIV PrEP
EP: 6.Patient Adherence to HIV PrEP
EP: 7.HIV PrEP and Multidisciplinary Care
EP: 8.Addressing Disparities and Increasing Access to HIV PrEP
EP: 9.Preventive Health Guidelines and Payer Support for HIV PrEP
EP: 10.Developments in HIV Prophylaxis: New PrEP Options
EP: 11.Long-Acting Injectable PrEP Therapy for HIV
EP: 12.Opportunities for HIV PrEP in Population Health
EP: 13.Reducing Barriers to PrEP Therapy
EP: 14.Battling Inequities in Access to PrEP
EP: 15.US Preventive Services Task Force’s Recommendation for PrEP
EP: 16.Opportunities for Long-Acting PrEP Therapies
EP: 17.Expanding PrEP Access
EP: 18.Opportunities for identifying and addressing barriers to HIV PrEP
Carl Schmid: There are great opportunities for increasing PrEP [pre-exposure prophylaxis]. I’m excited that President Biden will hopefully include a PrEP program in his upcoming 2023 budget. It has already been a focus of the Ending the HIV Epidemic in the US initiative, but it’s been limited. We need to expand the opportunities for PrEP. The goal of the National Strategic Plan that President Biden updated and released on World AIDS Day in 2022 says that we need to increase [the use of] PrEP to at least 50% of all the people who need it by 2025. That’s just in a couple of years. But to do that, we need to ramp up PrEP funding and community outreach. It’s great that President Biden will hopefully propose a program, but then we need Congress to support it as well. There are great opportunities ahead, but we need to educate our policymakers. Then, in turn, we need to educate the community and providers about the availability and the miracle of what we have with PrEP.
This transcript has been edited for clarity.
Examining Health Equity Among Different Racial and Ethnic Subpopulations With Multiple Sclerosis
March 15th 2021Multiple sclerosis (MS) is a chronic disease that involves demyelination of plaque throughout the white and gray matter of the central nervous system. The early stages of MS are usually marked by a relapsing-remitting course of neurological deficits, which progress toward continuous, permanent dysfunction and disability. Of those with a diagnosis of MS, 74% are women.
Read More
Improving Ophthalmic Care Access and Treatment Among Aging Adults
August 20th 2020As the American population ages, chronic conditions are becoming an increasing challenge for payers. In addition to conditions such as cardiovascular disease and diabetes, eye disease is also prevalent among aging adults.
Read More
